Gold bars to be exempt from tariffs, White House clarifies
DUBLIN - Investment firm LMR Partners LLP has disclosed a 2.99% stake in Mural Oncology plc, according to a regulatory filing submitted Thursday.
The disclosure, made under Rule 8.3 of the Irish Takeover Panel Act, reveals that LMR Partners holds 516,417 shares in the oncology-focused company. The filing also reports a minor transaction involving the sale of a single share at $2.45.
The position disclosure comes amid potential takeover activity surrounding Mural Oncology, though no specific acquisition offer has been confirmed in the filing. Irish takeover rules require investors holding stakes of 1% or more to disclose their positions when a company becomes subject to offer period regulations.
LMR Partners indicated it does not hold any derivative positions in Mural Oncology and is not making disclosures regarding any other party potentially involved in an offer.
The disclosure was submitted to the Irish Takeover Panel as an opening position statement, suggesting this is the firm’s first required filing regarding its Mural Oncology holdings under the relevant takeover rules.
This information is based on a regulatory press release statement filed with the London Stock Exchange (LON:LSEG)’s news service.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.